A Multicenter Randomized Double-Blind Placebo-Controlled Multiple Dose Study to Evaluate the Efficacy and Safety of VIS649 in Participants with Immunoglobulin A (IgA) Nephropathy
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
